WTTC urges the United States to approve the AstraZeneca vaccine
The World Travel & Tourism Council (WTTC) has urged the US government to expedite the clearance of the AstraZeneca vaccine in order to assist restore essential transatlantic travel.
The Pfizer vaccine was approved this week by the Centers for Disease Control (CDC), the primary health authority in the United States.
However, AstraZeneca is still not recognized as an approved Covid-19 vaccination.
Even if the Biden Administration allows borders to reopen, AstraZeneca’s non-recognition will be a substantial obstacle to transatlantic travel between the UK and the US, according to the WTTC.
The majority of Brits, and many millions more across the world, who have been immunized with AstraZeneca medicine will effectively be barred from entering the country.
AstraZeneca has the broadest worldwide reach of any current vaccine, having been administered in 176 nations and territories, emphasizing the importance of its approval in the United States.
According to the WTTC, CDC non-recognition will continue to substantially weaken consumer demand and hinder any meaningful revival of transatlantic travel from the United Kingdom to the United States.
It will also have a significant impact on the tourism industry on both sides of the Atlantic.
Another stunning hotel on a private island is coming to the Maldives
Every time Six Senses builds a new hotel, it is recognized for...
Etihad Airways is giving away complimentary Expo 2020 tickets
All Etihad Airways passengers flying into or out of Abu Dhabi will...
Qatar Airways will begin Almaty flights in November
Qatar Airways will begin scheduled passenger flights to Almaty, Kazakhstan, on November...
Travel SOPS extended for inbound passengers till Oct 31, CAA
The Civil Aviation Authority (CAA) has extended the Covid-19 standard operating procedures...
Finnair makes an official announcement regarding codeshare deal with Turkish Airlines
Finnair and Turkish Airlines have established a codeshare arrangement that will provide...